rs113488591
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014384.3(ACAD8):āc.512C>Gā(p.Ser171Cys) variant causes a missense change. The variant allele was found at a frequency of 0.021 in 1,613,960 control chromosomes in the GnomAD database, including 407 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.015 ( 20 hom., cov: 32)
Exomes š: 0.022 ( 387 hom. )
Consequence
ACAD8
NM_014384.3 missense
NM_014384.3 missense
Scores
7
7
4
Clinical Significance
Conservation
PhyloP100: 5.81
Genes affected
ACAD8 (HGNC:87): (acyl-CoA dehydrogenase family member 8) This gene encodes a member of the acyl-CoA dehydrogenase family of enzymes that catalyze the dehydrogenation of acyl-CoA derivatives in the metabolism of fatty acids or branch chained amino acids. The encoded protein is a mitochondrial enzyme that functions in catabolism of the branched-chain amino acid valine. Defects in this gene are the cause of isobutyryl-CoA dehydrogenase deficiency.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012948006).
BP6
Variant 11-134259029-C-G is Benign according to our data. Variant chr11-134259029-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 95589.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-134259029-C-G is described in Lovd as [Likely_pathogenic]. Variant chr11-134259029-C-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0153 (2323/152298) while in subpopulation NFE AF= 0.0236 (1606/68036). AF 95% confidence interval is 0.0226. There are 20 homozygotes in gnomad4. There are 1079 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACAD8 | NM_014384.3 | c.512C>G | p.Ser171Cys | missense_variant | 5/11 | ENST00000281182.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACAD8 | ENST00000281182.9 | c.512C>G | p.Ser171Cys | missense_variant | 5/11 | 1 | NM_014384.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0153 AC: 2323AN: 152180Hom.: 20 Cov.: 32
GnomAD3 genomes
AF:
AC:
2323
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0143 AC: 3590AN: 251482Hom.: 40 AF XY: 0.0139 AC XY: 1896AN XY: 135918
GnomAD3 exomes
AF:
AC:
3590
AN:
251482
Hom.:
AF XY:
AC XY:
1896
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0216 AC: 31539AN: 1461662Hom.: 387 Cov.: 31 AF XY: 0.0210 AC XY: 15273AN XY: 727138
GnomAD4 exome
AF:
AC:
31539
AN:
1461662
Hom.:
Cov.:
31
AF XY:
AC XY:
15273
AN XY:
727138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0153 AC: 2323AN: 152298Hom.: 20 Cov.: 32 AF XY: 0.0145 AC XY: 1079AN XY: 74470
GnomAD4 genome
AF:
AC:
2323
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
1079
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
91
ALSPAC
AF:
AC:
105
ESP6500AA
AF:
AC:
38
ESP6500EA
AF:
AC:
190
ExAC
AF:
AC:
1740
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | ACAD8: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 27, 2018 | This variant is associated with the following publications: (PMID: 22995991, 17304052, 24635911, 27535533, 30626930) - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Deficiency of isobutyryl-CoA dehydrogenase Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Benign, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | - | The heterozygous p.Ser171Cys variant in ACAD8 has been reported in the compound heterozygous state in an individual with isobutyryl-CoA dehydrogenase deficiency (PMID: 17304052), but has been classified as benign for autosomal recessive isobutyryl-CoA dehydrogenase deficiency because it was identified in >2% of European (non-Finnish) chromosomes and 20 homozygotes by ExAC (http://gnomad.broadinstitute.org/), and less than 5 affected individuals have ever been reported. - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 12, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;.
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at